Enzalutamide (enzalutamide) to be included in medical insurance prices in 2024

Enzalutamide (Enzalutamide) is a drug used to treat prostate cancer and belongs to the category of anti-androgen therapies. It is commercialized in the United States under the brand name "Xtandi".

Prostate cancer is one of the most common cancers in men and is often related to androgens. Androgens are male hormones, such as testosterone, that promote the growth and progression of prostate cancer. Enzalutamide (enzalutamide) works by inhibiting the effects of androgens, thereby blocking the growth and spread of prostate cancer cells.

Enzalutamide (enzalutamide) is now on the market in China and has been included in the scope of medical insurance. Patients can purchase it domestically at a price of approximately four to five thousand yuan. For detailed price information and specific policies on medical insurance reimbursement, please consult your local hospital pharmacy directly for accurate answers. It is worth mentioning that there are more affordable generic drug options in foreign markets, especially Indian generic drugs. The price is about more than 2,000 yuan, which is only about half of the domestic price. Importantly, these generic drugs are essentially identical in composition to the brand-name drugs, thus providing a more economical treatment option.

Specifically, enzalutamide is an androgen receptor antagonist that inhibits the proliferation of prostate cancer cells by binding to androgen receptors and preventing androgens from binding and activating these receptors. In addition, it enhances its anti-cancer effects by inhibiting the activation of other growth signaling pathways in prostate cancer cells, such as cell cycle regulation, apoptosis, and invasion.

Enzalutamide is commonly used to treat advanced prostate cancer, particularly in patients who have metastasized or are resistant to other antiandrogen therapies. It can be used as a single agent or in combination with other treatments, such as surgery, radiation or chemotherapy.

In clinical trials, enzalutamide has shown significant efficacy in extending patient survival and improving quality of life. However, like all medications, enzalutamide may cause some side effects, including fatigue, high blood pressure, dizziness, headache, and musculoskeletal pain. Therefore, doctors will weigh the benefits against the risks and monitor the patient's response when using enzalutamide .